Why do bypass surgery

Overview

Coronary artery bypass grafting (CABG), commonly known as heart bypass surgery, is a surgical procedure developed to treat severe coronary artery disease (CAD), where plaque buildup (atherosclerosis) narrows or blocks the coronary arteries that supply blood to the heart muscle. The modern era of CABG began in 1967 when Argentine surgeon Dr. Rene Favaloro performed the first successful coronary artery bypass using a saphenous vein graft at the Cleveland Clinic. This revolutionary procedure addressed the limitations of existing treatments for coronary artery disease, which previously included medications like nitroglycerin and more invasive procedures like the Vineberg operation (implanting the internal mammary artery directly into heart muscle). The development of CABG coincided with advances in cardiopulmonary bypass machines, which allowed surgeons to temporarily take over heart and lung function during surgery. By the 1970s, CABG had become standardized, with the internal mammary artery emerging as the preferred graft due to its superior long-term patency rates. Today, CABG remains a cornerstone treatment for complex coronary artery disease, though it now competes with less invasive options like percutaneous coronary intervention (PCI) with stents.

How It Works

During CABG surgery, surgeons create new pathways (bypasses) for blood to flow around blocked coronary arteries. The procedure typically begins with harvesting healthy blood vessels from other parts of the patient's body, most commonly the internal mammary artery from the chest wall or the saphenous vein from the leg. The patient is placed on a heart-lung bypass machine, which oxygenates the blood and circulates it throughout the body while the heart is temporarily stopped. Surgeons then attach one end of the graft vessel to the aorta (the main artery leaving the heart) and the other end to the coronary artery beyond the blockage, creating a detour for blood flow. For multi-vessel disease, multiple grafts may be placed—this is called double, triple, or quadruple bypass depending on how many arteries are bypassed. In some cases, surgeons perform off-pump coronary artery bypass (OPCAB) without using the heart-lung machine, which may reduce certain complications. The grafts restore adequate blood supply to the heart muscle, relieving symptoms like chest pain (angina) and reducing the risk of heart attack.

Why It Matters

CABG surgery significantly impacts patient survival and quality of life for those with severe coronary artery disease. Clinical studies have demonstrated that CABG reduces mortality by approximately 40% compared to medical therapy alone for patients with left main coronary artery disease or three-vessel disease with impaired heart function. Beyond survival benefits, CABG effectively relieves debilitating angina in over 90% of patients, allowing them to resume normal activities and improving their overall quality of life. The procedure has evolved with minimally invasive techniques and robotic-assisted surgery, reducing recovery time and complications. CABG remains particularly important for diabetic patients with multi-vessel disease, as studies show better long-term outcomes compared to stent placement. As cardiovascular disease remains the leading cause of death globally, responsible for approximately 17.9 million deaths annually according to the World Health Organization, CABG continues to play a crucial role in managing advanced coronary artery disease and preventing heart attacks.